No Data
Express News | Artiva Biotherapeutics Appoints Alison Moore, Ph.d., to Its Board of Directors
Press Release: Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
TD Cowen Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating
TD Cowen analyst Tyler Van Buren maintains $Artiva Biotherapeutics(ARTV.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 48.8% and a total average return of 1.6%
Needham Reiterates Buy on Artiva Biotherapeutics, Maintains $23 Price Target
Wedbush Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $18
Wedbush analyst David Nierengarten maintains $Artiva Biotherapeutics(ARTV.US)$ with a buy rating, and maintains the target price at $18.According to TipRanks data, the analyst has a success rate of 45
No Data
No Data
